Management of rhinosinusitis: an evidence based approach.
Management of rhinosinusitis: an evidence based approach.
复制标题
鼻窦炎的治疗：基于证据的方法。
DOI：
10.1097/aci.0000000000000276
复制
发表时间：
2016
影响因子：
2.8
通讯作者：
Peters,AnjuT
中科院分区：
文献类型：
--
作者：
Para,AndrewJ;Clayton,Elisabeth;Peters,AnjuT
急性呼吸道综合征的治疗主要包括用鼻内皮质类固醇和鼻盐水冲洗控制症状；抗生素应保留给被认为患有细菌性鼻窦炎的患者。有效治疗CRS包括使用鼻内皮质类固醇和冲洗、全身皮质类固醇和潜在的全身抗生素。生物制剂（mab）已在临床研究中显示出益处。提供者也应该意识到伴随的疾病过程可能会折磨CRS患者。
The treatment of ARS primarily involves symptomatic control with intranasal corticosteroids and nasal saline irrigation; antibiotics should be reserved for the patients who are believed to have bacterial rhinosinusitis. Treating CRS effectively involves using intranasal corticosteroids and irrigation, systemic corticosteroids, and potentially systemic antibiotics. Biologics (mAbs) have shown benefit in clinical studies. Providers should also be aware of concomitant disease processes that may afflict patients with CRS.